Eli Lilly Corp. buy UBS Group AG
Start price
20.10.23
/
50%
€557.00
Target price
20.10.24
€670.67
Performance (%)
38.59%
Price
06.06.24
€768.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Eli Lilly Corp. has seen massive gains of 38.59%. Dividends of €3.44 are taken into consideration when calculating the performance. This prediction currently runs until 20.10.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 2.099% | 2.099% |
iShares Core DAX® | 0.805% | 2.118% |
iShares Nasdaq 100 | 1.995% | 4.071% |
iShares Nikkei 225® | 1.264% | -2.374% |
iShares S&P 500 | 1.637% | 2.287% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at UBS Group AG. They now have a $710.00 price target on the stock, up previously from $612.00.
Ratings data for LLY provided by MarketBeat
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24